Trade 3SBio Inc. - 1530 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.10 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02228% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.000362% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.65 |
| Open | 5.65 |
| 1-Year Change | -19.86% |
| Day's Range | 5.45 - 5.65 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 22, 2024 | 5.65 | 0.00 | 0.00% | 5.65 | 5.65 | 5.60 |
| Nov 21, 2024 | 5.65 | -0.15 | -2.59% | 5.80 | 5.80 | 5.60 |
| Nov 20, 2024 | 5.75 | 0.00 | 0.00% | 5.75 | 5.80 | 5.65 |
| Nov 19, 2024 | 5.70 | 0.05 | 0.88% | 5.65 | 5.70 | 5.60 |
| Nov 18, 2024 | 5.65 | -0.05 | -0.88% | 5.70 | 5.70 | 5.60 |
| Nov 15, 2024 | 5.70 | -0.15 | -2.56% | 5.85 | 6.00 | 5.70 |
| Nov 14, 2024 | 5.75 | 0.00 | 0.00% | 5.75 | 5.90 | 5.70 |
| Nov 13, 2024 | 5.80 | 0.05 | 0.87% | 5.75 | 5.80 | 5.70 |
| Nov 12, 2024 | 5.80 | -0.05 | -0.85% | 5.85 | 5.85 | 5.70 |
| Nov 11, 2024 | 5.80 | -0.15 | -2.52% | 5.95 | 6.00 | 5.80 |
| Nov 8, 2024 | 6.00 | -0.05 | -0.83% | 6.05 | 6.15 | 5.95 |
| Nov 7, 2024 | 5.95 | 0.10 | 1.71% | 5.85 | 5.95 | 5.80 |
| Nov 6, 2024 | 5.85 | -0.10 | -1.68% | 5.95 | 5.95 | 5.80 |
| Nov 5, 2024 | 5.90 | 0.15 | 2.61% | 5.75 | 5.95 | 5.75 |
| Nov 4, 2024 | 5.75 | -0.10 | -1.71% | 5.85 | 5.85 | 5.70 |
| Nov 1, 2024 | 5.80 | 0.00 | 0.00% | 5.80 | 5.85 | 5.75 |
| Oct 31, 2024 | 5.80 | -0.10 | -1.69% | 5.90 | 5.90 | 5.80 |
| Oct 30, 2024 | 5.85 | -0.15 | -2.50% | 6.00 | 6.05 | 5.85 |
| Oct 29, 2024 | 6.00 | -0.20 | -3.23% | 6.20 | 6.20 | 6.00 |
| Oct 28, 2024 | 6.15 | 0.00 | 0.00% | 6.15 | 6.25 | 6.10 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
3SBio Company profile
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.| Industry: | Biopharmaceuticals |
瀋陽經濟技術開發區十號路1甲3號
SHENYANG
LIAONING
CN
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com